Madhya Pradesh government rushes to distribute Remdesivir to various districts by aircraft
Two hundred boxes containing 9,264 Remdesivir injections (a key anti-viral drug) have arrived at the Indore airport, an official from the Chief Minister's Office said.
Apr 15, 2021, 21:31 PM IST
Strict action against hoarding, black marketing of Remdesivir: Union Health Minister Dr Harsh Vardhan
Union Health Minister Dr Harsh Vardhan on Wednesday (April 14) said that those who are creating artificial shortage of the medicine will have to face strict action.
Apr 14, 2021, 19:01 PM IST
Price of COVID-19 drug Remdesivir to be capped between Rs 1100-1400 per dose: Maharashtra Health Minister Rajesh Tope
Maharashtra Health Minister Rajesh Tope said on Wednesday (April 7) that the price of COVID-19 drug Remdesivir to be capped between Rs 1100-1400 per dose, citing the high number of daily consumption in the state,
Apr 07, 2021, 15:29 PM IST
Foreign Secretary Harsh Shringla calls on Nepal PM KP Oli, hands over 2000 vials of Remdesivir
During the visit, FS called on Nepal Foreign Minister Pradeep Gyawali and Nepal PM K P Sharma Oli. He also handed over 2000 vials of Remdesivir as part of New Delhi's assistance to Nepal to deal with the COVID crisis.
Nov 26, 2020, 20:58 PM IST
Don't use Gilead's Remdesivir in hospitalised COVID-19 patients: WHO
A World Health Organization panel has said that Gilead`s Remdesivir should not be used for patients hospitalised with COVID-19.
Nov 21, 2020, 02:31 AM IST
WHO advises against this COVID-19 drug for hospitalised patients
A World Health Organisation panel on Friday said the drug is not recommended for hospitalised COVID-19 patients as there is no evidence it improves survival or reduces the need for ventilation.
Nov 20, 2020, 06:14 AM IST
WHO says Remdesivir has little or no effect on COVID-19 patients
WHO study found the regimens appeared to have little or no effect on 28-day mortality or the length of the in-hospital course among patients hospitalized with COVID-19.
Oct 16, 2020, 14:47 PM IST
Remdesivir, hydroxychloroquine did not cut hospital stay or mortality in COVID-19 patients: WHO
Gilead Sciences Inc`s remdesivir had little or no effect on COVID-19 patients` length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
Oct 16, 2020, 11:08 AM IST
One in three South Korean COVID-19 patients improve with remdesivir
One in three South Korean patients seriously ill with COVID-19 showed an improvement in their condition after being given Gilead Sciences Inc`s antiviral remdesivir, health authorities said.
Jul 13, 2020, 10:20 AM IST
Remdesivir, Tocilizumab, Favipiravir cannot be sold without medical prescription, says Drug Control department
The Delhi government's Drug Control Department on Friday (July 11, 2020) said that COVID-19 drug namely Remdesivir, Tocilizumab, Favipiravir should only be used for emergency purpose and directed the state drugs controller to keep a check on the selling of these medicines.
Jul 11, 2020, 08:42 AM IST
COVID-19: Hetero gets DCGI nod to launch anti-viral drug remdesivir
The company has received the manufacturing and marketing approval for Remdesivir from the Drug Controller General of India (DCGI) for the treatment of COVID-19, it said in a statement.
Jun 21, 2020, 14:38 PM IST
Maharashtra to procure 10,000 vials of Remdesivir as COVID-19 cases reach 82,968
The Uddhav Thackeray-led Maha Vikas Aghadi government in Maharashtra will purchase 10,000 vials of the drug Remdesivir for treating coronavirus patients. The announcement was made by state’s Public Health Minister Rajesh Tope said on Saturday.
Jun 06, 2020, 20:37 PM IST
Gilead ties up with generic drugmakers in India, Pakistan for coronavirus COVID-19 drug supply
Gilead Sciences Inc said on Tuesday it has signed non-exclusive licensing pacts with five generic drugmakers based in India and Pakistan to expand the supply of its experimental COVID-19 treatment remdesivir.
May 13, 2020, 07:17 AM IST
Data on Gilead drug remdesivir raises hopes in COVID-19 fight, Fauci calls it 'highly significant'
The top US infectious disease official said Gilead Sciences Inc`s experimental antiviral drug remdesivir will become the standard of care for COVID-19 after early clinical trial results on Wednesday showed it helped patients recover more quickly from the illness caused by the coronavirus.
Apr 30, 2020, 11:01 AM IST
